Combinations Alliance

The Combinations Alliance is a joint initiative between the Cancer Research UK Centre for Drug Development (CDD), the Experimental Cancer Medicine Centres (ECMC) Network and pharmaceutical collaborators developed in alignment with Cancer Research UK’s vision to bring forward the day when all cancers are cured. 

You are here

For researchers

Need support in translating your early phase combination research idea into a clinical trial? Read how we can support you bring your early phase combination idea to clinic.

For patients

The Combinations Alliance aims to bring people with cancer more treatment options by supporting preclinical and clinical combination treatment research.

For industry

Opportunity to broaden potential markets for commercial drugs by building rationale and facilitating access to the ECMC network in the UK.